Paola Piccolo
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Regional differences in care of cirrhotic patients in Internal Medicine: Results of a nationwide FADOI survey.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: October 31, 2025
"Real world" efficacy of bulevirtide in HBV/HDV-related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spallanzani in Rome, Italy.
Journal: HIV medicine
Published: April 02, 2023
Real-world use of remdesivir for the treatment of patients admitted to Italian hospitals with COVID-19: the nationwide retrospective FADOI-RECOVER study.
Journal: BMC infectious diseases
Published: March 10, 2023
Third dose of SARS-CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 30, 2022
High prevalence of asymptomatic SARS-CoV-2 infection in a cohort of liver transplant recipients in central Italy.
Journal: Journal of liver transplantation
Published: September 29, 2021
Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 02, 2021
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study.
Journal: Clinical transplantation
Published: November 12, 2017
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: the TT4 randomized trial.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: July 25, 2013
A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B.
Journal: Antiviral therapy
Published: June 06, 2012
Amantadine for treatment of hepatitis C: time to say "enough is enough"?
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: April 14, 2010
A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.
Journal: Antiviral therapy
Published: December 25, 2009
Last Updated: 09/26/2026